Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Post by Steveminon Mar 08, 2022 5:38pm
288 Views
Post# 34497332

Where are all of the Adams fanboys?

Where are all of the Adams fanboys?What??? Are all of you pumpers and Adams fanboys not happy with Eric's leadership of the company?
How could that be?
I thought you all said that his last 5 years have been perfectly executed. 

Now do you see why I've said he should've been gone long ago? The decisions he has made and the lack of progress and direction (over the last few years) are really causing the stock/company to get annihilated. We are paying for his sins as a terrible leader.

Don't be surpirised if they raise cash again in the coming months.
Don't be surpised if they do another reverse split in order to keep from getting delisted from the Nasdaq.
This is an endless cycle that has gone on for his whole time as CEO. He has got to go - for the sake of what's left of the company and the shareholders value (as meager as it may be).

I actually think he will step down before long - he knows the jig is up.....
<< Previous
Bullboard Posts
Next >>